INO (INO) Stock Price & Analysis
INO (INO) rose 5.15% to USD 1.43 as of September 8, 2026 at 05:00 UTC, according to Nexqual real-time market data.
INO last closed at USD 1.43; the session ranged USD 1.35–1.43 on volume of 2,910,140 shares. Market capitalization is —, with a 52-week range of USD 0.56–2.98 (NCM). Source: Nexqual, September 8, 2026 at 05:00 UTC.
Key Statistics (as of September 8, 2026 at 05:00 UTC)
| Price | USD 1.43 |
|---|---|
| Change | ▲ 5.15% (up) |
| Previous Close | USD 1.43 |
| Open | USD 1.43 |
| Day Range | USD 1.35 – 1.43 |
| 52-Week Range | USD 0.56 – 2.98 |
| Volume | 2,910,140 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (INO)
Nexqual's technical model rates INO "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 05:00 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 66.94 (neutral) |
| vs SMA50 | Above (USD 1.08) |
| MACD | 0.11 (positive) |
From INO's Latest SEC 10-K Filing (filed 2026-03-12)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VXRT | Vaxart, Inc. | USD 0.5 | ▲ 2.04% |
| NVAX | Novavax, Inc. | USD 10.22 | ▼ 0.97% |
| SRNE | Sorrento Therapeutics, Inc. | USD 0 | ▲ 0% |
| MRNA | Moderna, Inc. | USD 145.55 | ▼ 3.49% |
| CODX | Co-Diagnostics, Inc. | USD 1.16 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:00 UTC. This page is informational and not investment advice.